histamine H3 agonists (Hokkaido University/Yamanouchi)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehistamine H3 agonists (Hokkaido University/Yamanouchi)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor agonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsUlcerInflammationSleep Wake Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHokkaido University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYamanouchi Pharmaceutical Co LtdHokkaido University
Active IndicationsN/A
Inactive IndicationsUlcerInflammationSleep Wake Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksN/A